Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...
Hosted on MSN14d
Costs for MS, Parkinson's and Alzheimer's Meds Keep RisingA person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that ...
The Epilepsy Society was pleased to receive a reply from Health Minister, Karin Smyth in response to our letter calling for a top-to-toe review of the.
The company will still have some catching up to do, as LM-299 is early in clinical development, with a phase 1 trial ...
Researchers from Auburn University, partnering with the University of Basel in Switzerland, have discovered a new way to make ...
It is estimated that around 274,000 people in France suffer from Parkinson’s disease. The vast majority of them follow a ...
A Hot Springs man was arrested early Saturday on felony charges after allegedly fleeing from Hot Springs police with multiple ...
People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study examined the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback